Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Organon Pharma Indonesia Tbk. (SCPI) vs Tembaga Mulia Semanan Tbk. (TBMS) Price & Performance

Organon Pharma Indonesia Tbk.Trade
Tembaga Mulia Semanan Tbk.Trade

Price performance (Past 24H)

Key statistics

Organon Pharma Indonesia Tbk. vs Tembaga Mulia Semanan Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Tembaga Mulia Semanan Tbk. trades at Rp1,225 (market cap 914.68B, 27.3K 24h volume). The key difference: Tembaga Mulia Semanan Tbk. is far larger — about 8.8× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.

SCPITBMS
Market Cap
104.4B914.68B
Volume
27.3K
Lot
273
Turnover
33.53M
Average Price
1,228.15
Value
33.53M
Indicative Equilibrium Price
1,245
Indicative Equilibrium Volume
100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

SCPI
View details
TBMS
View details

About Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Read more on SCPI

About Tembaga Mulia Semanan Tbk.

PT. Tembaga Mulia Semanan Tbk was incorporated based on the Notarial Deed No. 31 dated February 3, 1977 of Kartini Muljadi, S.H., as amended by Notarial Deed No. 48 dated July 6, 1977 of the same notary. The company has started commercial production since Dec 1979. And started production/assembly of electronics wire/cable in 1993. Drawn wire in 1995 and assembly of optical fibre cable in 1998, tinned copper in 1998.

Read more on TBMS